Prostate Cancer - Global Drug Forecast and Market Analysis to 2023 for the $8.2 Billion Market
Transcription
Prostate Cancer - Global Drug Forecast and Market Analysis to 2023 for the $8.2 Billion Market "PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2023" report to their offering. Prostate Cancer Treatment Market Value Will Treble to $8.2 Billion by 2023 The global treatment market value for prostate cancer, excluding hormonal and bone therapies, will expand more than threefold from $2.6 billion in 2013 to an estimated $8.2 Billion. This report, "PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2023" focuses on the current treatment landscape, unmet needs, pipeline assessment and market outlook for prostate cancer. Browse Detailed Toc, Tables, Figures, Charts and Companies Mentioned in Prostate Cancer - Global Drug Forecast and Market Analysis Report at – http://www.absolutereports.com/pharmapointprostate-cancer-global-drug-forecast-and-market-analysis-to-2023-10076081 Scope of The Prostate Cancer - Global Drug Forecast and Market Analysis Report: - Overview of prostate cancer, including epidemiology, etiology, pathophysiology, clinical staging, symptoms, prognosis, quality of life, and disease management. - Annualized prostate cancer therapeutics market revenue from 2013-2023. Annual cost of therapy, and major marketed and pipeline drug sales in this forecast period are included. Ask for Discount on Prostate Cancer - Global Drug Forecast and Market Analysis Report at – http://www.absolutereports.com/enquiry/request-discount/10076081 Key Questions Answered in This Report: - How will prostate cancer disease management change as new agents enter the market? - Which prostate cancer patients have the greatest unmet needs and how well will these needs be addressed by the new agents? - What are the most dominant players in the prostate cancer space and what corporate strategies are +1 408 520 9750 www.absolutereports.com pursued by these companies? - What are the most promising late-stage pipeline agents for prostate cancer? How do they compare to currently marketed products? - What opportunities will remain for future players following the launch of these pipeline agents? Request sample PDF of this report at - http://www.absolutereports.com/enquiry/requestsample/10076081 The key findings of the reports is that the prostate cancer pipeline is robust with nine drugs in late-stage development. While androgen biosynthesis is still a major target, many of the pipeline candidates have diverse mechanisms of action and target proteins and pathways that are not targeted by the currently marketed prostate cancer treatments. Among these new candidates are a checkpoint inhibitor, a clusterin inhibitor, and an anti-angiogenic agent. There are also several vaccines, both autologous and off-the-shelf, that have a significant presence in this pipeline. About Absolute Report: Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters. Contact– Mr. Ameya Pingaley Absolute Reports +1-408 520 9750 Email – [email protected] Website: www.absolutereports.com +1 408 520 9750 www.absolutereports.com
Similar documents
Medtronic plc, Bioventus LLC and Depuy Companies Dominate the UK Orthobiologics Market Report
The orthobiologics market in the UK is expected to be driven by patient demographics, the development of novel product designs, increasing patient awareness, increasing participation in sports related activities, and a rising incidence of road accidents. The data in the report is derived from dynamic market forecast models.
More informationVentricular Fibrillation: Global Industry Analysis, Trends, Market Demands, Segment and Forecast
Ventricular Fibrillation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India.
More informationFrance Orthopedic Prosthetics Procedure report to 2021, Market Shares, Research Report, Industry Analysis, Forecast Opportunity
prosthesis is a functional replacement for an amputated or congenitally malformed or missing limb. Prosthetists are responsible for the prescription, design and management of a prosthetic device. In most cases, the prosthetist begins by taking a plaster cast of the patient's affected limb. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Lower Extremity Prosthetics and Upper Extremity Prosthetics.
More information